To better assess the correlations of the two polymorphisms of TEAD3 and HCC survival, stratified analysis was performed on age, gender, smoking and drinking status, BCLC stage, and chemotherapy/TACE status. The gene discussed is TEAD3; the disease is hepatocellular carcinoma.